[{"id":"50719c7c-1135-486c-b135-71ad28c7d4ea","acronym":"","url":"https://clinicaltrials.gov/study/NCT04405778","created_at":"2021-01-19T19:50:10.388Z","updated_at":"2024-07-02T16:35:25.199Z","phase":"Phase 1","brief_title":"A Study of TAK-102 in Adult With Previously-Treated Solid Tumors","source_id_and_acronym":"NCT04405778","lead_sponsor":"Takeda","biomarkers":" GPC3","pipe":" | ","alterations":" GPC3 expression","tags":["GPC3"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e GPC3 expression"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e NIB102"],"overall_status":"Active, not recruiting","enrollment":" Enrollment 11","initiation":"Initiation: 07/10/2020","start_date":" 07/10/2020","primary_txt":" Primary completion: 12/31/2026","primary_completion_date":" 12/31/2026","study_txt":" Completion: 12/31/2026","study_completion_date":" 12/31/2026","last_update_posted":"2023-12-27"}]